| Literature DB >> 35694079 |
Amit Kumar Verma1, Rudrashish Haldar1, Shashi Srivastava1, Kuntal Kanti Das2, Prabhaker Mishra3.
Abstract
Background Agents like propofol, sevoflurane, and desflurane having rapid revival of psychomotor and cognitive functions translating into reliable anesthetic recovery are chosen for day care procedures. This prospective randomized comparative study was undertaken to compare the psychomotor and cognitive functions of patients undergoing discectomy under different anesthetic strategies. Methods Seventy-five adult American Society of Anesthesiologists grade I and II patients being operated for endoscopic lumbar discectomy under different anesthetic regimens were enrolled and were subjected to Trieger Dot Test (TDT), Digit Symbol Substitution Test (DSST), and Mini-Mental State Examination (MMSE) preoperatively at specified intervals postoperatively. There emergence and early recovery times, complications, and satisfaction levels were also noted. Results No difference was found in the postoperative TDT and DSST and MMSE scores among the groups at all the time points (15 minutes, 3 minutes, 1 hour, 2 hours, 3 hours, and 4 hours). TDT and DSST demonstrated a tendency to return to baseline by 2nd and 3rd hour postoperatively. Emergence and early recovery times were earlier in the inhalation groups ( p 0.005 and 0.007, respectively). Time required to attain a Modified Aldrete Score of 9, complications, and observed side effects were similar among the groups. Conclusion Patients in the three groups had similar impairments in their psychomotor and cognitive functions which recovered at comparable time periods postoperatively. Emergence and early recovery were, however, faster in the desflurane group. Association for Helping Neurosurgical Sick People. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).Entities:
Keywords: Mini-Mental State Examination; cognitive functions; day care; lumbar discectomy; postoperative period
Year: 2022 PMID: 35694079 PMCID: PMC9187405 DOI: 10.1055/s-0042-1743443
Source DB: PubMed Journal: J Neurosci Rural Pract ISSN: 0976-3155
Fig. 1CONSORT Statement.
Distribution of demographic parameters and clinical variables between three study groups ( N = 75)
| Variables | Group 1 (D) | Group 2 (P) | Group 3 (S) | |
|---|---|---|---|---|
| Age (y) | 36.52 ± 16.30 | 40.16 ± 13.35 | 37.76 ± 12.89 |
0.658
|
|
Sex (male)
| 15 (60) | 16 (64) | 15 (60) | 0.946 |
|
ASA grade I
| 21 (84) | 21 (84) | 24 (96) | 0.321 |
|
ASA grade II
| 4 (16) | 4 (16) | 1 (4) | |
| Height (cm) | 161.52 ± 5.71 | 160.48 ± 4.81 | 161.56 ± 6.33 | 0.747 |
| Weight (kg) | 63.12 ± 6.72 | 62.80 ± 9.79 | 62.32 ± 9.97 | 0.951 |
| BMI (kg/m 2 ) | 24.21 ± 2.57 | 24.44 ± 3.08 | 23.72 ± 2.54 | 0.639 |
| B/L Digit Symbol Substitution Test | 16.92 ± 2.77 | 16.24 ± 2.92 | 16.64 ± 2.86 | 0.699 |
| B/L Trieger Dot Test | 7.44 ± 3.34 | 8.04 ± 3.62 | 7.36 ± 3.93 | 0.771 |
| B/L Mini–Mental State Examination | 28.28 ± 1.79 | 28.08 ± 1.82 | 28.08 ± 1.89 | 0.906 |
| Dose of thiopentone (mg) | 306.00 ± 29.12 | 305.00 ± 72.89 | 296.00 ± 40.62 | 0.748 |
| Dose of fentanyl (mcg) | 152.00 ± 44.44 | 190.00 ± 88.98 | 174.00 ± 63.11 | 0.147 |
| Total fluids (L) | 2.54 ± 0.56 | 2.60 ± 0.39 | 2.56 ± 0.63 | 0.934 |
| Blood loss (mL) | 156.80 ± 106.21 | 174.17 ± 84.80 | 181.60 ± 119.71 |
0.214
|
| Duration of surgery | 174.20 ± 39.63 | 179.80 ± 39.62 | 176.00 ± 38.73 | 0.876 |
| Duration of anesthesia | 209.60 ± 41.96 | 222.20 ± 48.13 | 213.80 ± 42.21 | 0.593 |
Abbreviations: ANOVA, analysis of variance; ASA, American Society of Anesthesiologists; BMI, body mass index; B/L, baseline; IQR, interquartile range; SD, standard deviation.
Note: Percentages are given within parenthesis. For skewed data, median (IQR) also given with mean ± SD. For normal continuous data, mean ± SD, one-way ANOVA test used. p < 0.05 significant.
Proportions were compared using Fisher's exact test.
Compared by Kruskal–Wallis H test.
Perioperative hemodynamic variables between and within the groups ( N = 75)
| Preinduction | 30 min | 1 h | 2 h | 3 h | 4 h | 5 h | |
|---|---|---|---|---|---|---|---|
| SBP | |||||||
| Group D | 126.44 ± 9.69 | 117.28 ± 11.29 | 114.52 ± 9.64 | 116.64 ± 8.08 |
117.9 ± 9.4 (
|
117.42 ± 10.81 (
| 121.08 ± 15.55 |
|
Group P (
| 126.48 | 116.44 ± 14.66 | 113.96 ± 11.2 | 115.16 ± 9.03 | 119.48 ± 8.01 |
123.67 ± 13.22 (
| 116.64 ± 12.44 |
|
Group S (
| 122.48 ± 11.64 | 115.44 ± 12.34 | 114.6 ± 10.47 | 113.96 ± 12.73 | 117.91 ± 9.86 | 118.67 | 112.75 |
| 0.446 | 0.879 | 0.973 | 0.647 | 0.792 | 0.256 | 0.298 | |
| DBP | |||||||
| Group D | 77.16 ± 7.61 | 70.88 ± 6.68 | 60.24 ± 6.46 | 71.16 ± 7.24 |
71.71 ± 6.29 (
|
73.47 ± 4.77 (
|
75.67 ± 11.79 (
|
|
Group P (
| 78.68 ± 9.60 | 72.24 ± 10 | 69.72 ± 7.74 | 71.28 ± 9.34 | 74.76 ± 7.42 |
77.40 ± 10.79 (
|
72.73 ± 10.50 (
|
|
Group S (
| 76.68 ± 7.34 | 72.20 ± 9.53 | 69.52 ± 13.09 | 73.48 ± 10.11 |
73.50 ± 7.07 (
|
73.67 ± 7.51 (
|
69.83 ± 4.57 (
|
| 0.674 | 0.827 | 0.984 | 0.591 | 0.311 | 0.286 | 0.204 | |
| HR | |||||||
| Group D | 80.72 ± 9.25 | 75.56 ± 9.33 | 74.32 ± 7.68 | 75.48 ± 7.13 | 76.00 ± 7.14 | 76.11 ± 9.42 | 73.83 ± 8.84 |
|
Group P (
| 81.44 ± 10.87 | 77.60 ± 10.49 | 75.40 ± 9.91 | 76.88 ± 8.51 | 77.00 ± 9.20 | 82.93 ± 10.75 | 79.82 ± 7.92 |
|
Group S (
| 79.20 ± 10.10 | 76.92 ± 10.33 | 73.40 ± 8.19 | 74.52 ± 8.45 | 76.81 ± 8.18 | 78.39 ± 7.71 | 73.75 ± 6.77 |
| 0.727 | 0.767 | 0.716 | 0.584 | 0.896 | 0.111 | 0.107 | |
| Temperature | |||||||
| Group D | 36.14 ± 0.24 | 36.10 ± 0.29 | 36.08 ± 0.31 | 36.09 ± 0.29 | 36.06 ± 0.19 | 36.10 ± 0.30 | 36.21 ± 0.36 |
|
Group P (
| 36.17 ± 0.38 | 36.17 ± 0.39 | 36.11 ± 0.35 | 36.16 ± 0.37 | 36.18 ± 0.42 | 36.28 ± 0.37 | 36.44 ± 0.36 |
|
Group S (
| 36.10 ± 0.33 | 36.06 ± 0.25 | 36.05 ± 0.33 | 36.06 ± 0.34 | 36.11 ± 0.31 | 36.06 ± 0.31 | 36.13 ± 0.33 |
| 0.781 | 0.470 | 0.653 | 0.533 | 0.415 | 0.127 | 0.209 | |
| SPO2 | |||||||
| Group D | 99.84 ± 0.55 | 99.84 ± 0.47 | 99.84 ± 0.55 | 99.84 ± 0.55 | 99.88 ± 0.45 | 99.89 ± 0.32 | 100.00 ± 00 |
|
Group P (
| 99.88 ± 0.44 | 99.88 ± 0.44 | 99.88 ± 0.44 | 100.00 ± 00 | 99.96 ± 0.20 | 99.87 ± 0.52 | 99.82 ± 0.6 |
|
Group S (
| 99.64 ± 0.91 | 99.68 ± 0.85 | 99.80 ± 0.65 | 99.92 ± 0.40 | 99.82 ± 0.59 | 99.89 ± 0.47 | 100 ± 00 |
| 0.439 | 0.483 | 0.878 | 0.363 | 0.532 | 0.981 | 0.346 | |
| ETCO2 | |||||||
| Group D | 33.04 ± 1.62 | 33.00 ± 2.04 | 32.52 ± 2.43 | 32.79 ± 1.35 | 33.11 ± 2.85 | 32.33 ± 1.44 | |
|
Group P (
| 32.88 ± 2.01 | 33.04 ± 1.59 | 32.76 ± 1.64 | 32.24 ± 1.56 | 32.67 ± 1.95 | 33.00 ± 2.10 | |
|
Group S (
| 33.64 ± 2.20 | 33.20 ± 1.53 | 32.84 ± 1.70 | 32.95 ± 1.68 | 33.00 ± 0.91 | 32.75 ± 1.06 | |
| 0.355 | 0.911 | 0.835 | 0.246 | 0.823 | 0.592 | ||
Abbreviations: ANOVA, analysis of variance; DBP, diastolic blood pressure; ETCO2, end-tidal carbon dioxide level; HR, heart rate; SBP, systolic blood pressure; SD, standard deviation; SPO2, oxygen saturation.
Note: Mean ± SD, one-way ANOVA test used to compare means among the three study groups. p < 0.05 significant.
Scoring patterns in the cognitive and psychomotor tests of the patients in three groups ( N = 75)
| DSST | ||||||
|---|---|---|---|---|---|---|
| 15 min | 30 min | 1 h | 2 h | 3 h | 4 h | |
| Group D | 6.84 ± 5.32 | 11.12 ± 5.01 | 14.32 ± 3.50 | 16.80 ± 2.71 | 16.80 ± 2.89 | 16.88 ± 2.74 |
|
Group P (
| 5.64 ± 5.28 | 10.28 ± 4.50 | 13.52 ± 3.43 | 16.08 ± 2.63 | 16.08 ± 2.68 | 16.20 ± 2.57 |
|
Group S (
| 6.16 ± 5.14 | 10.64 ± 4.99 | 13.56 ± 3.65 | 16.28 ± 2.32 | 16.44 ± 2.42 | 16.48 ± 2.73 |
| 0.721 | 0.829 | 0.666 | 0.592 | 0.636 | 0.667 | |
| TDT | ||||||
|
|
|
|
|
|
| |
| Group D | 24.72 ± 10.66 | 17.76 ± 8.61 | 11.52 ± 4.74 | 7.48 ± 2.65 | 7.48 ± 3.42 | 7.48 ± 3.34 |
|
Group P (
| 27.20 ± 11.11 | 17.56 ± 6.47 | 12.32 ± 4.54 | 8.28 ± 2.57 | 8.04 ± 3.03 | 8.20 ± 3.64 |
|
Group S (
| 25.52 ± 11.24 | 17.48 ± 8.76 | 12.32 ± 5.74 | 7.84 ± 3.14 | 7.80 ± 3.59 | 7.40 ± 3.86 |
| 0.719 | 0.992 | 0.811 | 0.602 | 0.840 | 0.692 | |
| MMSE | ||||||
|
|
|
|
|
|
| |
| Group D | 21.64 ± 2.16 | 24.64 ± 2.45 | 26.68 ± 2.39 | 28.24 ± 1.59 | 28.24 ± 1.56 | 28.20 ± 1.68 |
|
Group P (
| 21.40 ± 2.08 | 24.00 ± 1.94 | 26.20 ± 2.04 | 28.04 ± 1.62 | 27.96 ± 1.67 | 27.92 ± 1.66 |
|
Group S (
| 21.68 ± 2.50 | 24.32 ± 2.53 | 26.20 ± 2.43 | 27.72 ± 1.77 | 27.80 ± 1.50 | 27.96 ± 1.88 |
| 0.893 | 0.623 | 0.696 | 0.539 | 0.610 | 0.828 | |
Abbreviations: ANOVA, analysis of variance; DSST, Digit Symbol Substitution Test; MMSE, Mini-Mental State Examination; SD, standard deviation; TDT, Trieger Dot Test.
Note: Mean ± SD, one-way ANOVA test used to compare means among three study groups. p < 0.05 significant.
Fig. 2Intragroup change in Digit Symbol Substitution Test (as compared with baseline) at different time intervals.
Fig. 3Intragroup change in Trieger Dot Test scores (as compared with baseline) at different time intervals.
Fig. 4Intragroup change in Mini–Mental State Examination scores (as compared with baseline) at different time intervals.
Fig. 5Comparison of emergence times and early recovery time in between the groups.
Comparison of emergence times, early recovery times, and time to achieve Modified Aldrete Score of 9 among the groups
| Parameters |
Group D (
|
Group P (
|
Group S (
| |
|---|---|---|---|---|
| Emergence time (min) | 8.18 ± 2.26 | 11.35 ± 5.08 | 8.88 ± 2.25 |
|
| Early recovery time (min) | 10.63 ± 2.85 | 13.99 ± 5.67 | 11.08 ± 2.58 |
|
| Time taken to achieve MAS of 9 (min) | 148.20 ± 38.81 | 143.60 ± 31.04 | 148.20 ± 39.76 | 0.878 |
Abbreviations: ANOVA, analysis of variance; MAS, Modified Aldrete Score; SD, standard deviation.
Note: Mean ± SD, one-way ANOVA test used to compare means among three study groups. Bonferroni correction methods used for multiple comparisons.
p < 0.05 significant.
Comparison of side effects observed within the groups
| A: Comparison of side effects observed within the groups | ||||||
|---|---|---|---|---|---|---|
| Giddiness | Headache | Nausea | Vomiting | Pain at injection site | ||
|
Group D (
| 1 (4%) | 1 (4) | 4 (16%) | 3 (12%) | 0 (0%) | 0.651 |
|
Group P (
| 1 (4%) | 0 | 1 (4%) | 1 (4%) | 0 (0%) | |
|
Group S (
| 0 (0%) | 1 (4%) | 2 (8%) | 2 (8%) | 0 (0%) | |
| B: Comparison of ratings of the quality of anesthesia delivery by the patients | ||||||
|
|
|
|
|
| ||
|
Group D (
| 8 (32%) | 17 (68%) | 0 (0%) | 0 (0%) | 0.568 | |
|
Group P (
| 5 (20%) | 19 (76%) | 1 (4%) | 0 (0%) | ||
|
Group S (
| 7 (28%) | 16 (64%) | 2 (8%) | 0 (%) | ||
Note: Data expressed in numbers and percentage, Fisher's exact test used. p < 0.05 significant.